世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
インターベンショナルオンコロジー市場 製品別［アブレーション高周波焼灼装置、マイクロ波焼灼装置、クライオアブレーション装置、その他］、粒子塞栓術（ラジオエンボリック剤、薬剤溶出ビーズ、その他）、サポートデバイス］。世界の機会分析および産業予測、2021-2031年Interventional Oncology Market By Product [Ablation Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Others), Particle Embolization (Radioembolic agents, Drug-Eluting Beads, and Others), Support Devices]: Global Opportunity Analysis and Industry Forecast, 2021–2031 インターベンショナル腫瘍学の世界市場規模は、2021年の21億3130万ドルから急増し、注目すべきCAGR6.5％で2030年には最大37億9150万ドルに達すると予測されます。 インターベンショナル・オンコロジー（IO）は、... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーインターベンショナル腫瘍学の世界市場規模は、2021年の21億3130万ドルから急増し、注目すべきCAGR6.5％で2030年には最大37億9150万ドルに達すると予測されます。インターベンショナル・オンコロジー（IO）は、がん治療を改善するために画像誘導による処置（診断／手術）を行うことに焦点を当てた新しい専門分野である。外科手術、薬物療法、放射線療法と並んで、IOは現在、現代の腫瘍治療の4本目の柱となっています。世界中の人々の間でがん患者が増加していることから、インターベンショナルオンコロジー市場は予測期間中に拡大を加速させると予想されています。がんは、世界で最も急速に増加している健康問題の一つであり、乳幼児から高齢者まで、あらゆる年齢の人々に影響を与えています。乳がんや咽頭がんは、人々に最も多く見られるがんの一種です。このように、がん患者数の増加に伴い、がん治療に対する技術的なニーズも高まっています。このことは、今後数年間における市場の積極的な拡大に寄与すると予測されます。しかし、インターベンショナル・オンコロジー療法は比較的新しい治療法であるため、市場への浸透度は低く、認知度も低いのが現状です。 世界のインターベンショナルオンコロジー市場は、製品タイプ、がんタイプ、エンドユーザーに基づいてセグメント化されています。製品タイプに基づいて、市場は塞栓装置、アブレーション装置、サポート装置に分けられています。がん種では、肝臓がん、肺がん、骨転移、腎臓がん、乳がん、前立腺がん、その他のがんに分類されます。エンドユーザー別では、病院、外来手術センター、研究・学術機関に分類されます。地域別では、北米、欧州、アジア太平洋地域、LAMEAに分類されます。 インターベンショナルオンコロジー市場の主要企業には、Medtronic、Boston Scientific、BD、Terumo、Merit Medical、AngioDynamics、J&J、Teleflex、Cook Medical、HealthTronicsなどが挙げられます。 主要市場セグメント 製品タイプ別 塞栓用デバイス アブレーションデバイス サポートデバイス がんタイプ別 肝臓がん 肺がん 骨転移 腎臓がん 乳がん 前立腺癌 その他の癌 エンドユーザー別 病院 外来手術センター 研究機関・学術機関 地域別 北アメリカ 米国 カナダ メキシコ 欧州 ドイツ フランス イギリス イタリア スペイン その他の地域 アジア太平洋地域 日本 中国 インド オーストラリア 韓国 その他のアジア太平洋地域 ラメア ブラジル サウジアラビア サウジアラビア首長国 南アフリカ共和国 LAMEAの残りの地域 キープレイヤー メドトロニック ボストン・サイエンティフィック BD テルモ メリットメディカル アンジオダイナミクス J&J テレフレックス クックメディカル ヘルストロニクス 主な市場セグメント 製品別 アブレーション ラジオ波焼灼装置 マイクロ波焼灼装置 凍結焼灼装置 その他 粒子線塞栓療法 ラジオ・エンボリック剤 薬剤溶出性ビーズ その他 サポートデバイス 地域別 北米 米国 カナダ メキシコ 欧州 ドイツ フランス イギリス イタリア スペイン その他のヨーロッパ アジア太平洋地域 日本 中国 オーストラリア インド 韓国 台湾 その他のアジア太平洋地域 LAMEA ブラジル トルコ サウジアラビア 南アフリカ LAMEAの他の地域 主な市場関係者 Alpinion Medical Systems Co.Ltd. アンジオダイナミクス ボストン・サイエンティフィック社 ホロジック社 メドトロニック・ピーエルシー メリットメディカル プロファウンドメディカル シーメンス ヘルスィニアス テレフレックス・インコーポレイテッド テルモ株式会社 目次CHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market 3.7.Value Chain Analysis 3.8.Key Regulation Analysis 3.9.Market Share Analysis 3.10.Regulatory Guidelines CHAPTER 4: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT TYPE 4.1 Overview 4.1.1 Market size and forecast 4.2 Embolization Devices 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Ablation Devices 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country 4.4 Support Devices 4.4.1 Key market trends, growth factors and opportunities 4.4.2 Market size and forecast, by region 4.4.3 Market analysis by country CHAPTER 5: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE 5.1 Overview 5.1.1 Market size and forecast 5.2 Liver Cancer 5.2.1 Key market trends, growth factors and opportunities 5.2.2 Market size and forecast, by region 5.2.3 Market analysis by country 5.3 Lung Cancer 5.3.1 Key market trends, growth factors and opportunities 5.3.2 Market size and forecast, by region 5.3.3 Market analysis by country 5.4 Breast Cancer 5.4.1 Key market trends, growth factors and opportunities 5.4.2 Market size and forecast, by region 5.4.3 Market analysis by country 5.5 Prostate Cancer 5.5.1 Key market trends, growth factors and opportunities 5.5.2 Market size and forecast, by region 5.5.3 Market analysis by country 5.6 Kidney Cancer 5.6.1 Key market trends, growth factors and opportunities 5.6.2 Market size and forecast, by region 5.6.3 Market analysis by country 5.7 Bone Metastasis 5.7.1 Key market trends, growth factors and opportunities 5.7.2 Market size and forecast, by region 5.7.3 Market analysis by country 5.8 Other Cancers 5.8.1 Key market trends, growth factors and opportunities 5.8.2 Market size and forecast, by region 5.8.3 Market analysis by country CHAPTER 6: INTERVENTIONAL ONCOLOGY MARKET, BY END USER 6.1 Overview 6.1.1 Market size and forecast 6.2 Hospitals 6.2.1 Key market trends, growth factors and opportunities 6.2.2 Market size and forecast, by region 6.2.3 Market analysis by country 6.3 Ambulatory Surgery Centers 6.3.1 Key market trends, growth factors and opportunities 6.3.2 Market size and forecast, by region 6.3.3 Market analysis by country 6.4 Research and Academic Institutes 6.4.1 Key market trends, growth factors and opportunities 6.4.2 Market size and forecast, by region 6.4.3 Market analysis by country CHAPTER 7: INTERVENTIONAL ONCOLOGY MARKET, BY REGION 7.1 Overview 7.1.1 Market size and forecast 7.2 North America 7.2.1 Key trends and opportunities 7.2.2 North America Market size and forecast, by Product Type 7.2.3 North America Market size and forecast, by Cancer Type 7.2.4 North America Market size and forecast, by End User 7.2.5 North America Market size and forecast, by country 7.2.5.1 U.S. 7.2.5.1.1 Market size and forecast, by Product Type 7.2.5.1.2 Market size and forecast, by Cancer Type 7.2.5.1.3 Market size and forecast, by End User 7.2.5.2 Canada 7.2.5.2.1 Market size and forecast, by Product Type 7.2.5.2.2 Market size and forecast, by Cancer Type 7.2.5.2.3 Market size and forecast, by End User 7.2.5.3 Mexico 7.2.5.3.1 Market size and forecast, by Product Type 7.2.5.3.2 Market size and forecast, by Cancer Type 7.2.5.3.3 Market size and forecast, by End User 7.3 Europe 7.3.1 Key trends and opportunities 7.3.2 Europe Market size and forecast, by Product Type 7.3.3 Europe Market size and forecast, by Cancer Type 7.3.4 Europe Market size and forecast, by End User 7.3.5 Europe Market size and forecast, by country 7.3.5.1 Germany 7.3.5.1.1 Market size and forecast, by Product Type 7.3.5.1.2 Market size and forecast, by Cancer Type 7.3.5.1.3 Market size and forecast, by End User 7.3.5.2 U.K. 7.3.5.2.1 Market size and forecast, by Product Type 7.3.5.2.2 Market size and forecast, by Cancer Type 7.3.5.2.3 Market size and forecast, by End User 7.3.5.3 France 7.3.5.3.1 Market size and forecast, by Product Type 7.3.5.3.2 Market size and forecast, by Cancer Type 7.3.5.3.3 Market size and forecast, by End User 7.3.5.4 Spain 7.3.5.4.1 Market size and forecast, by Product Type 7.3.5.4.2 Market size and forecast, by Cancer Type 7.3.5.4.3 Market size and forecast, by End User 7.3.5.5 Italy 7.3.5.5.1 Market size and forecast, by Product Type 7.3.5.5.2 Market size and forecast, by Cancer Type 7.3.5.5.3 Market size and forecast, by End User 7.3.5.6 Rest of Europe 7.3.5.6.1 Market size and forecast, by Product Type 7.3.5.6.2 Market size and forecast, by Cancer Type 7.3.5.6.3 Market size and forecast, by End User 7.4 Asia-Pacific 7.4.1 Key trends and opportunities 7.4.2 Asia-Pacific Market size and forecast, by Product Type 7.4.3 Asia-Pacific Market size and forecast, by Cancer Type 7.4.4 Asia-Pacific Market size and forecast, by End User 7.4.5 Asia-Pacific Market size and forecast, by country 7.4.5.1 China 7.4.5.1.1 Market size and forecast, by Product Type 7.4.5.1.2 Market size and forecast, by Cancer Type 7.4.5.1.3 Market size and forecast, by End User 7.4.5.2 Japan 7.4.5.2.1 Market size and forecast, by Product Type 7.4.5.2.2 Market size and forecast, by Cancer Type 7.4.5.2.3 Market size and forecast, by End User 7.4.5.3 India 7.4.5.3.1 Market size and forecast, by Product Type 7.4.5.3.2 Market size and forecast, by Cancer Type 7.4.5.3.3 Market size and forecast, by End User 7.4.5.4 South Korea 7.4.5.4.1 Market size and forecast, by Product Type 7.4.5.4.2 Market size and forecast, by Cancer Type 7.4.5.4.3 Market size and forecast, by End User 7.4.5.5 Australia 7.4.5.5.1 Market size and forecast, by Product Type 7.4.5.5.2 Market size and forecast, by Cancer Type 7.4.5.5.3 Market size and forecast, by End User 7.4.5.6 Rest Of Asia Pacific 7.4.5.6.1 Market size and forecast, by Product Type 7.4.5.6.2 Market size and forecast, by Cancer Type 7.4.5.6.3 Market size and forecast, by End User 7.5 LAMEA 7.5.1 Key trends and opportunities 7.5.2 LAMEA Market size and forecast, by Product Type 7.5.3 LAMEA Market size and forecast, by Cancer Type 7.5.4 LAMEA Market size and forecast, by End User 7.5.5 LAMEA Market size and forecast, by country 7.5.5.1 Brazil 7.5.5.1.1 Market size and forecast, by Product Type 7.5.5.1.2 Market size and forecast, by Cancer Type 7.5.5.1.3 Market size and forecast, by End User 7.5.5.2 Saudi Arabia 7.5.5.2.1 Market size and forecast, by Product Type 7.5.5.2.2 Market size and forecast, by Cancer Type 7.5.5.2.3 Market size and forecast, by End User 7.5.5.3 South Africa 7.5.5.3.1 Market size and forecast, by Product Type 7.5.5.3.2 Market size and forecast, by Cancer Type 7.5.5.3.3 Market size and forecast, by End User 7.5.5.4 Rest of LAMEA 7.5.5.4.1 Market size and forecast, by Product Type 7.5.5.4.2 Market size and forecast, by Cancer Type 7.5.5.4.3 Market size and forecast, by End User CHAPTER 8: COMPANY LANDSCAPE 8.1. Introduction 8.2. Top winning strategies 8.3. Product Mapping of Top 10 Player 8.4. Competitive Dashboard 8.5. Competitive Heatmap 8.6. Key developments CHAPTER 9: COMPANY PROFILES 9.1 Medtronic, Inc. 9.1.1 Company overview 9.1.2 Company snapshot 9.1.3 Operating business segments 9.1.4 Product portfolio 9.1.5 Business performance 9.1.6 Key strategic moves and developments 9.2 Boston Scientific Corporation 9.2.1 Company overview 9.2.2 Company snapshot 9.2.3 Operating business segments 9.2.4 Product portfolio 9.2.5 Business performance 9.2.6 Key strategic moves and developments 9.3 BD 9.3.1 Company overview 9.3.2 Company snapshot 9.3.3 Operating business segments 9.3.4 Product portfolio 9.3.5 Business performance 9.3.6 Key strategic moves and developments 9.4 Terumo Corporation 9.4.1 Company overview 9.4.2 Company snapshot 9.4.3 Operating business segments 9.4.4 Product portfolio 9.4.5 Business performance 9.4.6 Key strategic moves and developments 9.5 Merit Medical 9.5.1 Company overview 9.5.2 Company snapshot 9.5.3 Operating business segments 9.5.4 Product portfolio 9.5.5 Business performance 9.5.6 Key strategic moves and developments 9.6 AngioDynamics 9.6.1 Company overview 9.6.2 Company snapshot 9.6.3 Operating business segments 9.6.4 Product portfolio 9.6.5 Business performance 9.6.6 Key strategic moves and developments 9.7 Johnson & Johnson 9.7.1 Company overview 9.7.2 Company snapshot 9.7.3 Operating business segments 9.7.4 Product portfolio 9.7.5 Business performance 9.7.6 Key strategic moves and developments 9.8 Teleflex Incorporated 9.8.1 Company overview 9.8.2 Company snapshot 9.8.3 Operating business segments 9.8.4 Product portfolio 9.8.5 Business performance 9.8.6 Key strategic moves and developments 9.9 Cook Group 9.9.1 Company overview 9.9.2 Company snapshot 9.9.3 Operating business segments 9.9.4 Product portfolio 9.9.5 Business performance 9.9.6 Key strategic moves and developments 9.10 HealthTronics, Inc. 9.10.1 Company overview 9.10.2 Company snapshot 9.10.3 Operating business segments 9.10.4 Product portfolio 9.10.5 Business performance 9.10.6 Key strategic moves and developments
SummaryThe global interventional oncology market size is expected to reach up to $3,791.50 million by 2030, surging from $2,131.30 million in 2021, at a noteworthy CAGR of 6.5%. Table of ContentsCHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market 3.7.Value Chain Analysis 3.8.Key Regulation Analysis 3.9.Market Share Analysis 3.10.Regulatory Guidelines CHAPTER 4: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT TYPE 4.1 Overview 4.1.1 Market size and forecast 4.2 Embolization Devices 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Ablation Devices 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country 4.4 Support Devices 4.4.1 Key market trends, growth factors and opportunities 4.4.2 Market size and forecast, by region 4.4.3 Market analysis by country CHAPTER 5: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE 5.1 Overview 5.1.1 Market size and forecast 5.2 Liver Cancer 5.2.1 Key market trends, growth factors and opportunities 5.2.2 Market size and forecast, by region 5.2.3 Market analysis by country 5.3 Lung Cancer 5.3.1 Key market trends, growth factors and opportunities 5.3.2 Market size and forecast, by region 5.3.3 Market analysis by country 5.4 Breast Cancer 5.4.1 Key market trends, growth factors and opportunities 5.4.2 Market size and forecast, by region 5.4.3 Market analysis by country 5.5 Prostate Cancer 5.5.1 Key market trends, growth factors and opportunities 5.5.2 Market size and forecast, by region 5.5.3 Market analysis by country 5.6 Kidney Cancer 5.6.1 Key market trends, growth factors and opportunities 5.6.2 Market size and forecast, by region 5.6.3 Market analysis by country 5.7 Bone Metastasis 5.7.1 Key market trends, growth factors and opportunities 5.7.2 Market size and forecast, by region 5.7.3 Market analysis by country 5.8 Other Cancers 5.8.1 Key market trends, growth factors and opportunities 5.8.2 Market size and forecast, by region 5.8.3 Market analysis by country CHAPTER 6: INTERVENTIONAL ONCOLOGY MARKET, BY END USER 6.1 Overview 6.1.1 Market size and forecast 6.2 Hospitals 6.2.1 Key market trends, growth factors and opportunities 6.2.2 Market size and forecast, by region 6.2.3 Market analysis by country 6.3 Ambulatory Surgery Centers 6.3.1 Key market trends, growth factors and opportunities 6.3.2 Market size and forecast, by region 6.3.3 Market analysis by country 6.4 Research and Academic Institutes 6.4.1 Key market trends, growth factors and opportunities 6.4.2 Market size and forecast, by region 6.4.3 Market analysis by country CHAPTER 7: INTERVENTIONAL ONCOLOGY MARKET, BY REGION 7.1 Overview 7.1.1 Market size and forecast 7.2 North America 7.2.1 Key trends and opportunities 7.2.2 North America Market size and forecast, by Product Type 7.2.3 North America Market size and forecast, by Cancer Type 7.2.4 North America Market size and forecast, by End User 7.2.5 North America Market size and forecast, by country 7.2.5.1 U.S. 7.2.5.1.1 Market size and forecast, by Product Type 7.2.5.1.2 Market size and forecast, by Cancer Type 7.2.5.1.3 Market size and forecast, by End User 7.2.5.2 Canada 7.2.5.2.1 Market size and forecast, by Product Type 7.2.5.2.2 Market size and forecast, by Cancer Type 7.2.5.2.3 Market size and forecast, by End User 7.2.5.3 Mexico 7.2.5.3.1 Market size and forecast, by Product Type 7.2.5.3.2 Market size and forecast, by Cancer Type 7.2.5.3.3 Market size and forecast, by End User 7.3 Europe 7.3.1 Key trends and opportunities 7.3.2 Europe Market size and forecast, by Product Type 7.3.3 Europe Market size and forecast, by Cancer Type 7.3.4 Europe Market size and forecast, by End User 7.3.5 Europe Market size and forecast, by country 7.3.5.1 Germany 7.3.5.1.1 Market size and forecast, by Product Type 7.3.5.1.2 Market size and forecast, by Cancer Type 7.3.5.1.3 Market size and forecast, by End User 7.3.5.2 U.K. 7.3.5.2.1 Market size and forecast, by Product Type 7.3.5.2.2 Market size and forecast, by Cancer Type 7.3.5.2.3 Market size and forecast, by End User 7.3.5.3 France 7.3.5.3.1 Market size and forecast, by Product Type 7.3.5.3.2 Market size and forecast, by Cancer Type 7.3.5.3.3 Market size and forecast, by End User 7.3.5.4 Spain 7.3.5.4.1 Market size and forecast, by Product Type 7.3.5.4.2 Market size and forecast, by Cancer Type 7.3.5.4.3 Market size and forecast, by End User 7.3.5.5 Italy 7.3.5.5.1 Market size and forecast, by Product Type 7.3.5.5.2 Market size and forecast, by Cancer Type 7.3.5.5.3 Market size and forecast, by End User 7.3.5.6 Rest of Europe 7.3.5.6.1 Market size and forecast, by Product Type 7.3.5.6.2 Market size and forecast, by Cancer Type 7.3.5.6.3 Market size and forecast, by End User 7.4 Asia-Pacific 7.4.1 Key trends and opportunities 7.4.2 Asia-Pacific Market size and forecast, by Product Type 7.4.3 Asia-Pacific Market size and forecast, by Cancer Type 7.4.4 Asia-Pacific Market size and forecast, by End User 7.4.5 Asia-Pacific Market size and forecast, by country 7.4.5.1 China 7.4.5.1.1 Market size and forecast, by Product Type 7.4.5.1.2 Market size and forecast, by Cancer Type 7.4.5.1.3 Market size and forecast, by End User 7.4.5.2 Japan 7.4.5.2.1 Market size and forecast, by Product Type 7.4.5.2.2 Market size and forecast, by Cancer Type 7.4.5.2.3 Market size and forecast, by End User 7.4.5.3 India 7.4.5.3.1 Market size and forecast, by Product Type 7.4.5.3.2 Market size and forecast, by Cancer Type 7.4.5.3.3 Market size and forecast, by End User 7.4.5.4 South Korea 7.4.5.4.1 Market size and forecast, by Product Type 7.4.5.4.2 Market size and forecast, by Cancer Type 7.4.5.4.3 Market size and forecast, by End User 7.4.5.5 Australia 7.4.5.5.1 Market size and forecast, by Product Type 7.4.5.5.2 Market size and forecast, by Cancer Type 7.4.5.5.3 Market size and forecast, by End User 7.4.5.6 Rest Of Asia Pacific 7.4.5.6.1 Market size and forecast, by Product Type 7.4.5.6.2 Market size and forecast, by Cancer Type 7.4.5.6.3 Market size and forecast, by End User 7.5 LAMEA 7.5.1 Key trends and opportunities 7.5.2 LAMEA Market size and forecast, by Product Type 7.5.3 LAMEA Market size and forecast, by Cancer Type 7.5.4 LAMEA Market size and forecast, by End User 7.5.5 LAMEA Market size and forecast, by country 7.5.5.1 Brazil 7.5.5.1.1 Market size and forecast, by Product Type 7.5.5.1.2 Market size and forecast, by Cancer Type 7.5.5.1.3 Market size and forecast, by End User 7.5.5.2 Saudi Arabia 7.5.5.2.1 Market size and forecast, by Product Type 7.5.5.2.2 Market size and forecast, by Cancer Type 7.5.5.2.3 Market size and forecast, by End User 7.5.5.3 South Africa 7.5.5.3.1 Market size and forecast, by Product Type 7.5.5.3.2 Market size and forecast, by Cancer Type 7.5.5.3.3 Market size and forecast, by End User 7.5.5.4 Rest of LAMEA 7.5.5.4.1 Market size and forecast, by Product Type 7.5.5.4.2 Market size and forecast, by Cancer Type 7.5.5.4.3 Market size and forecast, by End User CHAPTER 8: COMPANY LANDSCAPE 8.1. Introduction 8.2. Top winning strategies 8.3. Product Mapping of Top 10 Player 8.4. Competitive Dashboard 8.5. Competitive Heatmap 8.6. Key developments CHAPTER 9: COMPANY PROFILES 9.1 Medtronic, Inc. 9.1.1 Company overview 9.1.2 Company snapshot 9.1.3 Operating business segments 9.1.4 Product portfolio 9.1.5 Business performance 9.1.6 Key strategic moves and developments 9.2 Boston Scientific Corporation 9.2.1 Company overview 9.2.2 Company snapshot 9.2.3 Operating business segments 9.2.4 Product portfolio 9.2.5 Business performance 9.2.6 Key strategic moves and developments 9.3 BD 9.3.1 Company overview 9.3.2 Company snapshot 9.3.3 Operating business segments 9.3.4 Product portfolio 9.3.5 Business performance 9.3.6 Key strategic moves and developments 9.4 Terumo Corporation 9.4.1 Company overview 9.4.2 Company snapshot 9.4.3 Operating business segments 9.4.4 Product portfolio 9.4.5 Business performance 9.4.6 Key strategic moves and developments 9.5 Merit Medical 9.5.1 Company overview 9.5.2 Company snapshot 9.5.3 Operating business segments 9.5.4 Product portfolio 9.5.5 Business performance 9.5.6 Key strategic moves and developments 9.6 AngioDynamics 9.6.1 Company overview 9.6.2 Company snapshot 9.6.3 Operating business segments 9.6.4 Product portfolio 9.6.5 Business performance 9.6.6 Key strategic moves and developments 9.7 Johnson & Johnson 9.7.1 Company overview 9.7.2 Company snapshot 9.7.3 Operating business segments 9.7.4 Product portfolio 9.7.5 Business performance 9.7.6 Key strategic moves and developments 9.8 Teleflex Incorporated 9.8.1 Company overview 9.8.2 Company snapshot 9.8.3 Operating business segments 9.8.4 Product portfolio 9.8.5 Business performance 9.8.6 Key strategic moves and developments 9.9 Cook Group 9.9.1 Company overview 9.9.2 Company snapshot 9.9.3 Operating business segments 9.9.4 Product portfolio 9.9.5 Business performance 9.9.6 Key strategic moves and developments 9.10 HealthTronics, Inc. 9.10.1 Company overview 9.10.2 Company snapshot 9.10.3 Operating business segments 9.10.4 Product portfolio 9.10.5 Business performance 9.10.6 Key strategic moves and developments
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（薬学的薬物）の最新刊レポートAllied Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD（oncology）の最新刊レポート
よくあるご質問Allied Market Research社はどのような調査会社ですか?アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |
